The agreement, which runs for 36 months with the possibility of extension, guarantees ZymIQ a fixed revenue level throughout the period. It replaces the previous agreement between the parties and means that ZymIQ will now manufacture all products in fjör’s range as well as be responsible for the development of new products.

fjör (www.fjor.life) is an innovative skincare brand built on biomimetic principles and scientifically developed formulations. The products utilize ZymIQ’s enzyme technology and are designed to support the skin’s barrier function and promote microbial diversity — key to maintaining a balanced and resilient skin. fjör has received international recognition in leading publications such as Vogue, Financial Times, The Handbook, Esquire, and Stylist.

“Our collaboration is built on a shared commitment to breakthrough science, integrity and purpose. Together, we’ve created something that goes beyond skincare, products that reflect years of research, mutual trust and a belief in advancing how we care for the skin,” says Natalie Enslöw, Founder and CEO of fjör.

“That fjör is now scaling up its operations shows that their products are appreciated by customers around the world. I am delighted to see fjör’s continued success and expansion,” says Michael Edelborg Christensen, CEO of ZymIQ.